First published · Last updated
Danshensu attenuates type 2 diabetes-related osteoporosis via the PI3K/AKT/Nrf2 signaling pathway
A peer-reviewed journal article reports that the compound danshensu reduces osteoporosis associated with type 2 diabetes by modulating the PI3K/AKT/Nrf2 signaling pathway.
Categories: science-and-space, public-health, positive-progress
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 7/10
- Urgency
- 2/10
Why it matters
This finding suggests a potential therapeutic approach for bone loss linked to type 2 diabetes.

